Gauthier Julie

Effects of plasma from bivalve mollusk species on the in vitro proliferation of the protistan parasite Perkinsus marinus.

Nucleotide sequence of the p53 cDNA of beluga whale (Delphinapterus leucas).

Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test.

cDNA cloning and characterization of two iron superoxide dismutases from the oyster parasite Perkinsus marinus.

Mutation screening of FOXP2 in individuals diagnosed with autistic disorder.

Superoxide dismutases from the oyster parasite Perkinsus marinus: purification, biochemical characterization, and development of a plate microassay for activity.

A serosurvey of leptospirosis in Connecticut peridomestic wildlife.

Flow cytometric analysis of lectin binding to in vitro-cultured Perkinsus marinus surface carbohydrates.

NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population.

Capillary electrophoresis separation of a mixture of chitin and chitosan oligosaccharides derivatized using a modified fluorophore conjugation procedure.

Clinical stringency greatly improves mutation detection in Rett syndrome.

Sleep and COMT polymorphism in ADHD children: preliminary actigraphic data.

Transmission disequilibrium study of an oligodendrocyte and myelin glycoprotein gene allele in 431 families with an autistic proband.

Novel de novo SHANK3 mutation in autistic patients.

Mutations in the calcium-related gene IL1RAPL1 are associated with autism.

Identification of drostanolone and 17-methyldrostanolone metabolites produced by cryopreserved human hepatocytes.

Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation.

No association between SRGAP3/MEGAP haploinsufficiency and mental retardation.

De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy.

[De novo mutations in SYNGAP1 associated with non-syndromic mental retardation].

De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia.

De novo truncating mutation in Kinesin 17 associated with schizophrenia.

Direct measure of the de novo mutation rate in autism and schizophrenia cohorts.

Role of GacA in virulence of Vibrio vulnificus.

Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability.

De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment.

Resequencing of 29 candidate genes in patients with familial and sporadic amyotrophic lateral sclerosis.

De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism.

Intellectual disability without epilepsy associated with STXBP1 disruption.

Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.

A population genetic approach to mapping neurological disorder genes using deep resequencing.

Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.

SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function.

Increased exonic de novo mutation rate in individuals with schizophrenia.

Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy.